INTRODUCTION
Vascular endothelial growth factor (VEGF) is the major angiogenic cytokine contributing to the regulation of physiological and pathological angiogenesis (1, 2) . Its expression levels in mammalian cells are very tightly regulated. In fact, a 50% reduction of VEGF expression during embryogenesis, as observed in VEGF +/-heterozygous mice, results in lethality (3, 4) . Reciprocally, overexpression of VEGF in adult tissues leads to the formation of angiomas and perturbs organ development (5) . VEGF expression is regulated by a number of environmental factors including hypoxia, growth factors and several hormones (1, 6) . With most of these factors, different levels of regulation are observed. First, VEGF transcription is activated by the binding of a number of transcription factors onto specific response elements located in the promoter of the VEGF gene. These include HIF-1α and AP-1 for the hypoxic response (7, 8) , Sp1 and AP-2 for the growth factor response (9, 10) . Second, VEGF mRNA stability is regulated in response to some of these effectors through the binding of stabilizing and destabilizing proteins to AU-rich elements (AREs) located in the 3'-untranslated region (3'-UTR) of VEGF mRNA (11) (12) (13) (14) . Third, translation of VEGF mRNA into protein is also a controlled mechanism implying several alternative initiation codons (15) . The choice of the preferential initiation codon is modified under hypoxic conditions (16) or under oncogenic transformation (17) . These different levels of regulation may cooperate to amplify the effects of such or such regulator. For example, hypoxia-induced stimulation of VEGF expression results from both HIF-1α-mediated stimulation of transcription (7) and HuR-mediated stabilization of VEGF mRNA (11) .
HuR is a ubiquitously expressed member of the ELAV (embryonic-lethal abnormal visual in Drosophila melanogaster) family of RNA binding proteins, which also comprises the neuron-specific proteins HuD, HuC and Hel-N1 (18, 19) . The protein products of all four genes bind with high affinity and specificity to AREs in a variety of mRNAs, such as those encoding VEGF, c-fos, c-jun, IL-3, TNFα, and GM-CSF, and are believed to increase mRNA stability, mRNA translation or both (20, 21) . We have previously reported that adrenocorticotropin (ACTH) rapidly and transiently stimulates VEGF expression by primary cultures of bovine adrenocortical cells (28).
Interestingly, we observed that this increase in VEGF mRNA was transcription-independent as it was still observed in the presence of DRB, a potent transcription inhibitor (28). We then characterized Tis11b (TPA-inducible-sequence 11b) as a zinc finger RNA-destabilizing protein whose synthesis is also induced by ACTH, although slightly later than that of VEGF (29). We hypothesized that Tis11b might play a role in the control of VEGF mRNA stability. Indeed, we recently characterized the interaction between Tis11b and VEGF mRNA 3'-UTR, and identified a 75 bp sequence in this 3'-UTR, containing two AU-rich elements, as the Tis11b binding-element (TBE) (30). We could show that Tis11b binding to TBE induces destabilization of VEGF mRNA, resulting in a reduction of VEGF mRNA half-life from 130 min down to 60 min. In the present work, we attempted to identify the mechanism by which ACTH induces VEGF mRNA.
We identified HuR as a potential regulator and could establish that ACTH induces a rapid increase of HuR levels in the cytoplasm and a concomitant decrease of HuR levels in the nucleus. Moreover, co-immunoprecipitations experiments revealed that ACTH induces a molecular complex between the nucleocytoplasmic shuttling protein pp32 and HuR in the cytoplasm, suggesting that pp32 is involved in HuR accumulation in this compartment. Finally, as the Tis11b-and HuR-binding sites are quite close to each other on the VEGF mRNA 3'-UTR, we wondered whether these two proteins might antagonize each other in the control of VEGF mRNA stability.
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RESULTS
Regulation of VEGF, Tis11b and HuR mRNAs expression by ACTH
We have previously shown that ACTH rapidly and transiently induces the expression of VEGF in primary cultures of adrenocortical cells (28). Moreover, we recently observed that Tis11b, through its mRNA destabilizing-activity, is involved in the decay phase of ACTH-elicited VEGF mRNA levels (30). However, the mechanisms involved in the induction phase of VEGF mRNA remained to be determined. As this induction was still observed in the presence of the transcription inhibitor DRB (28), we postulated that stabilization of VEGF mRNA might be involved in this process. Since the ELAV family members HuC, HuD and Hel-N1 were reported as neural-specific RNA-stabilizing proteins, we focused on HuR, the ubiquitously expressed member of ELAV proteins. We first examined the possible involvement of HuR in ACTH-induced increase of VEGF mRNA. Fig. 1A illustrates an RT-PCR analysis of VEGF, Tis11b and HuR mRNA levels in adrenocortical cells stimulated with 10 nM ACTH for various periods of time ranging from 0 to 5 h. As previously reported (29), VEGF mRNA levels peaked after 2-3 h whereas the hormone induced the expression of Tis11b between 3 and 5 h of treatment ( Fig. 1A and 1B) . In contrast, HuR mRNA levels were unchanged over the period of ACTH stimulation (Fig. 1A and 1B) . Northern blot analysis of HuR mRNA levels in ACTH-treated cells confirmed that they were very stable for up to 24 h of hormone treatment (maximal value reaching 137 ± 40 % of mRNA levels measured in nontreated cells, n=3, data not shown).
ACTH does not affect total HuR protein content of BAC cells
The above results prompted us to examine whether ACTH could exert a posttranscriptional effect by acting on HuR mRNA translation. As shown in Fig. 2A and 2B, following exposure of BAC cells to 10 nM ACTH, no significant changes were observed in HuR protein content of whole cell extracts. In contrast, ACTH induced a progressive increase in Tis11b protein content ( Fig. 2A and 2B ). This increase was apparent as early as 1 h after stimulation and peaked after 5-6 h. Tis11b protein expression remained slightly elevated 24 h after ACTH treatment (data not shown).
ACTH increases cytoplasmic levels of HuR
HuR appears predominantly located in the nucleus within all cell types examined so far (24). Moreover, HuR-induced stabilization of its mRNA targets is associated with an increase in cytoplasmic levels of HuR (24). To assess the subcellular distribution of HuR in BAC cells as well as the potential effect of ACTH on HuR localization, BAC cells were incubated with 10 nM ACTH for various periods of time ranging from 0 to 6 h, then subfractionated into nuclear and cytoplasmic fractions. As shown in Fig. 2C , HuR was weakly present in the cytoplasm (20 µg of cytoplasmic extracts) but was abundant in the nucleus (5 µg of nuclear extracts) of unstimulated cells. Quantitation of cytoplasmic and nuclear HuR revealed that ACTH treatment led to a 2 to 3-fold increase of cytoplasmic HuR as early as 30 min after stimulation and a concomitant decrease in nuclear HuR (Fig. 2D) . Cytoplasmic HuR levels remained elevated for up to 3 h then decreased by 4 h of stimulation. In unstimulated cells, HuR was estimated to be about 5 to 6-fold more abundant in the nucleus. Hybridization of the same membranes with antibodies recognizing cytoplasm-and nucleus-specific proteins (α-tubulin and lamin A/C, respectively) allowed us to verify that nuclear proteins did not leak into the cytoplasmic 8 fractions during cell fractionation (Fig. 2C) . To determine the subcellular localization of Tis11b in BAC cells, the same blots were probed with affinity-purified polyclonal antiTis11b antibodies (30). As shown on Fig. 2C , Tis11b was exclusively detected in the cytoplasmic fractions. Upon prolonged exposure of the membrane (15 min), a very weak Tis11b signal could be detected in the nuclear fractions (data not shown). Exposure of BAC cells to ACTH induced a robust increase in Tis11b protein levels in the cytoplasm (Fig. 2C) , which was correlated to the induction of Tis11b that we observed in whole cell extracts ( Fig. 2A) .
Altogether, these results indicate that ACTH treatment of BAC cells leads to a rapid increase of HuR protein content in the cytoplasm with a concomitant decrease of HuR protein content in the nucleus and to a delayed increase of Tis11b protein in the cytoplasm.
HuR interacts with the nucleocytoplasmic shuttling protein pp32 in BAC cells
In light of the observation that increases in cytoplasmic HuR are largely due to the CRM1-dependent export of nuclear HuR which involves complexes between HuR and the nucleocytoplasmic shuttling proteins pp32 and/or APRIL (26, 27), we further tested whether these proteins might contribute to ACTH-induced accumulation of HuR in the cytoplasm using co-immunoprecipitation experiments. As we could not detect APRIL in whole BAC cell extracts (data not shown), we focused on pp32. Cytoplasmic and nuclear BAC extracts were exposed to anti-pp32 antibody. Probing the immunoprecipitates with anti-HuR antibody revealed that pp32 is associated with HuR in the cytoplasm and that ACTH treatment increases this association (Fig 3A and 3B) . The same blot was probed with anti-pp32 antibody to check for pp32 immunoprecipitation. In the nucleus, HuR-pp32 complexes are less abundant as compared to the cytoplasm and are not significantly altered by hormone treatment (Fig 3A and 3B) . These results suggest that ACTH-induced increase in cytoplasmic HuR levels involves pp32-mediated HuR delocalization from the nucleus to the cytoplasm of BAC cells.
Leptomycin B prevents ACTH-induced expression of VEGF mRNA
CRM1-dependent nucleocytoplasmic shuttling of NES-containing proteins such as pp32 has been shown to be impaired by leptomycin B (LMB), a compound which covalently modifies a critical cystein residue in CRM1 and thereby prevents CRM1-pp32 interaction via NES (31). Moreover, CRM1 has been shown to be instrumental in the nuclear export of HuR (26, 27). Our observation that ACTH treatment stimulates the formation of HuRpp32 complexes in the cytoplasm prompted us to examine the effect of LMB on ACTHinduced increase in VEGF mRNA levels. BAC cells were stimulated with ACTH in the absence or in the presence of leptomycin B (LMB). As shown in Fig. 4A , the hormoneinduced increase of HuR in the cytoplasm was abolished at all time points of stimulation in the presence of LMB (5 ng/ml).
RT-PCR analysis of VEGF mRNA levels revealed that co-treatment of BAC cells with ACTH and LMB prevented the increase in VEGF mRNA expression elicited by ACTH (Fig. 4B) . Quantitation of two independent experiments showed that after 2 h of ACTH treatment, VEGF mRNA levels were induced up to 290 ± 60 % of control levels and that, in the presence of LMB, maximal induction reached only 147 ± 60 % of control levels.
LMB also had a discrete effect by itself on the basal expression of VEGF mRNA.
HuR knockdown inhibits ACTH-induced increase in VEGF mRNA levels 10 To provide further evidence of the involvement of HuR in the regulation of VEGF mRNA expression by ACTH, we used RNA interference to more selectively target HuR. Using a specific siRNA targeting exon 2 in HuR gene, we showed by both RT-PCR and Western blotting that this siRNA was effective in decreasing HuR mRNA and protein levels in BAC cells after 48 h of treatment ( Fig. 5A and 5B, time point 0). Quantitation of HuR mRNA level in three independent experiments revealed that HuR gene expression was knocked down by 70 to 85 % (data not shown). In these experiments, HuR protein levels were barely detectable upon prolonged exposure of the Western blot (data not shown).
BAC cells pre-treated either in the presence of a negative control siRNA or in the presence of HuR siRNA were further stimulated with 10 nM ACTH and VEGF mRNA levels were analyzed by RT-PCR. In this particular experiment, cells pre-treated with negative control siRNA displayed a 2.5-fold increase in VEGF mRNA expression after 4 h of exposure to ACTH (Fig. 5A and 5C ). In contrast, HuR siRNA impaired ACTHelicited up-regulation of VEGF mRNA levels ( Fig. 5A and 5C ). Moreover, silencing HuR expression led to a substantial reduction in basal VEGF mRNA expression down to 39 ± 19 % of controls (n=3, data not shown).
Antagonistic effects of Tis11b and HuR on VEGF mRNA
A previous study using co-transfections of Tis11b (pCMV-Tis11b) and firefly luciferase cDNA cloned upstream of VEGF mRNA 3'-UTR (Luc-V3' construct) allowed us to demonstrate that VEGF mRNA 3'-UTR confers a Tis11b-mediated decrease in reporter gene activity, which was closely related to a decrease in luciferase transcript stability (30). Furthermore, similar experiments using co-transfections of HuR and Luc-V3' construct revealed that HuR-induced increase in luciferase activity reflects an increase in luciferase transcript stability (32). Because HuR and Tis11b appear to have antagonistic activity on VEGF mRNA and since the Tis11b binding site on VEGF mRNA 3'-UTR is very close to a recently described HuR binding site (32), we investigated whether these two proteins could compete with each other to regulate VEGF mRNA expression. We first determined the effect of expressing each protein alone on luciferase activity. COS7 cells were transiently transfected with increasing doses of either pCMVTis11b or pCMV-HuR plasmids and a fixed concentration of Luc-V3'. Fig. 6A shows that luciferase activity was decreased in a dose-dependent manner by Tis11b, a statistically significant decrease being observed with a plasmid amount as low as 0.5 ng (62.5 ± 7.9 %, of controls, p<0.01, n=3). In contrast, HuR expression led to an increase in the reporter gene activity over a narrow window of the cotransfected HuR plasmid ( 
DISCUSSION
Vascular endothelial growth factor VEGF has been shown in mammals to be a key mediator of angiogenesis in such diverse physiological and pathological processes as embryogenesis, female oestrus cycle, diabetic retinopathy and tumor development (1).
The expression of the VEGF gene is controlled at many levels including transcription (10) , mRNA stability through the binding of regulatory proteins to the 3' untranslated region (33) and mRNA translation via IRES sequences located in the 5' untranslated region (15) . Post-transcriptional regulation of VEGF mRNA is a key control point in VEGF expression under hypoxic conditions. Indeed, hypoxia-mediated increase of VEGF mRNA levels is in a large part due to an increase in VEGF mRNA half-life following its stabilization by the RNA-binding protein HuR (11) .
Transcriptional regulation of VEGF expression by hormones in endocrine tissues, including endometrium, ovaries and adrenal cortex, has been extensively studied (34-39). In contrast, the possible involvement of post-transcriptional regulation in hormonally-regulated expression of VEGF has received much less attention to date. We have previously shown that the trophic hormone ACTH triggers a rapid and transient increase in VEGF mRNA levels in adrenocortical cells via transcription-independent mechanisms (28). We could further demonstrate that the decay phase of ACTH-induced VEGF mRNA levels involves the RNA-destabilizing protein Tis11b (30). In the current study, we aimed at investigating the molecular mechanisms of ACTH-elicited increase in VEGF mRNA levels. Four major conclusions can be drawn from the present work: 
MATERIALS AND METHODS
Reagents
Synthetic ACTH 1-24 was purchased from Neosystem (Strasbourg, France). Culture media and sera were from Invitrogen (Cergy Pontoise, France). All chemicals were obtained from Sigma (St Louis, MO) and were of the highest purity grade available.
Bovine adrenocortical cell (BAC) culture and treatments
Bovine adrenal glands were obtained from a local slaughterhouse. Zona fasciculatareticularis cells were prepared by enzymatic dispersion with trypsin and primary cultures were established as described in detail elsewhere (56). BAC cells were kept at 37 C in Ham's F12 medium supplemented with 10% horse serum, 2.5% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 20 μg/ml gentamycin, under 5% CO2 -95% air atmosphere. On day 4, cells cultured in 10-cm petri dishes (3 x 10 6 cells/dish) were stimulated with 10 nM ACTH for the indicated periods of time before subcellular fractionation or processing for total RNA isolation as described hereafter. In experiments designed to silence HuR expression (RNAi), BAC cells were transfected on day 2 of culture.
Preparation of subcellular fractions
Total cell extracts, as well as nuclear and cytoplasmic fractions were prepared using the PARIS protein and RNA isolation kit (Ambion, Austin, TX) according to the manufacturer's instructions. A protease inhibitor cocktail (10 μg/ml of leupeptin, 1 μg/ml of aprotinin, 1 μg/ml of pepstatin and 25 μg/ml of AEBSF) was added to the provided buffers. Briefly, 10-cm petri dishes (3 x 10 6 BAC cells/dish) were lysed on ice in 400 μl of Cell Disruption buffer and collected with a rubber spatula. A portion of the total cell lysate was used for RNA isolation (300 μl) and the remainder was kept for protein analysis (100 μl).
For nuclear and cytoplasmic lysate preparation, BAC cells (3 x 10 6 cells/ 10-cm petri dish) were trypsinized, washed in PBS then suspended in 400 μl of Cell Fractionation
Buffer. Following a 15 min-incubation on ice, nuclear and cytoplasmic fractions were separated by centrifugation (5 min at 500 x g). The nuclear pellet was lysed in 400 μl of Cell Disruption buffer and kept 10 min on ice to ensure complete disruption before processing the sample for protein analysis.
Protein concentration was determined using a Micro BCA protein Assay Kit (Pierce, Rockford, IL).
RNA isolation and Reverse Transcription-Polymerase Chain Reaction
BAC cell total RNA was extracted using the RNAgents kit (Promega Corp., PCR products were analyzed on 2% agarose ethidium bromide-containing gels and quantitated using ImageQuant software (FluorImager SI, Vistra Fluorescence).
Preliminary experiments were done to select the starting amounts of RNA so that there was a linear relationship between the amount of input RNA and the optical density of the HPRT band on ethidium bromide-stained gel.
SDS-Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis was performed according to Laemmli (57).
Total proteins or subcellular fraction extracts (5-20 µg/lane) were solubilized in sample buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 5% β-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue), boiled for 5 min and loaded onto a 12% SDS-PAGE minigel (Mini Protean II System, BioRad). Electrophoresis was performed at 150 V for 1 h. 
Western blot analysis
SDS-PAGE
Recombinant protein expression and purification
Tis11b recombinant protein was produced as reported in (30). GST-HuR fusion protein was produced using E. Coli BL21 strain transformed with pGEX-5X2-HuR plasmid (provided by Dr JA Steitz, Yale University school of Medicine, New Haven, USA).
Bacteria were grown at 37°C to an A 600 nm of 0.6 in 2YT medium (16 g/l tryptone, 10 g/l yeast extract, 5 g/l NaCl) containing 100 µg/ml of ampicillin. The GST-HuR fusion protein was induced with 0.1 mM IPTG for 2 hours, and purified using MicroSpin GST Purification Module (Amersham Biosciences) according to the manufacturer's instructions. Briefly, cells were harvested by centrifugation (2,500 x g at 4 C for 5 min).
The pellet was resuspended with ice-cold PBS containing 0.1 mg/ml lysozyme and lysed by repeated freeze/thawing (10 times). Clarified lysate was mixed for 10 min with Glutathione Sepharose 4B Microspin column. After two washes with PBS, GST-HuR fusion protein was eluted with 10 mM reduced glutathione. Purity of GST-HuR protein was examined by Coomassie blue staining following SDS-PAGE analysis.
RNA-protein UV cross-linking assay
[ 32 P]-rUTP labeled and unlabeled riboprobes were synthesized in vitro using pSp64
plasmid containing the entire VEGF 3'-UTR and the Riboprobe SP6 in vitro Transcription System (Promega). Integrity of RNA transcripts was visualized on 1% agarose ethidium bromide-containing gel. 1 x 10 6 cpm of RNA transcripts were incubated for 20 min at room temperature with 1 to 6 µg of either Tis11b-containing bacterial extract or GSTHuR fusion protein, in 10 mM HEPES pH 7.6, 3 mM MgCl 2 , 40 mM KCl, 5% glycerol, 0,5% NP40 and 2 mM DTT. Yeast tRNA (50 ng/µl) and heparin (2 µg/µl) were then added for 10 min. Mixtures were exposed to UV light for 30 min on ice. 100 U of RNase T1 (Invitrogen) were then added for 20 min and RNA-protein complexes were analyzed by 12% SDS-PAGE and autoradiography.
Statistical analysis
Results are expressed as means ± S.E. The mean values were compared by ANOVA using Fisher's test. A value of p<0.05 was considered as statistically significant.
Quantitation of immunoblots and autoradiograms was performed using a Molecular
Imager FX and Quantity One software (Biorad). 
ACKNOWLEDGMENTS
